Markus Koglin

Markus Koglin is a seasoned professional in protein chemistry with extensive experience in the biopharmaceutical sector. Currently serving as Senior Director of Protein Chemistry at Merck since May 2019, Markus Koglin has been instrumental in generating purified proteins for the early drug discovery pipeline. Prior to this role, Markus Koglin held the position of Executive Research Director at Sosei Heptares from January 2009 to April 2019, where oversight of protein expression and antigen production was a key responsibility, along with managing biopharmaceutical projects and collaborations. Markus Koglin began a career at GlaxoSmithKline as a Principal Scientist from January 2003 to December 2008. Educationally, Markus Koglin earned a PhD in Molecular Pharmacology from the University of Hamburg and a Master's degree in Molecular Biology from the University of Bochum.